AstraZeneca and Incyte Announce New Lung Cancer Clinical Trial Collaboration

… with EGFR mutation-positive non-small cell lung cancer (NSCLC), who have been treated … a potentially exciting combination for lung cancer patients who have developed a … EGFR T790M mutation-positive non-small cell lung cancer. This indication is approved under …